
Imagion Biosystems Ltd
ASX:IBX

Intrinsic Value
The intrinsic value of one
IBX
stock under the Base Case scenario is
0.02
AUD.
Compared to the current market price of 0.012 AUD,
Imagion Biosystems Ltd
is
Undervalued by 41%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Imagion Biosystems Ltd
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Imagion Biosystems Ltd
Balance Sheet Decomposition
Imagion Biosystems Ltd
Current Assets | 2.8m |
Cash & Short-Term Investments | 2.7m |
Receivables | 900 |
Other Current Assets | 114.1k |
Non-Current Assets | 18.2k |
PP&E | 18.3k |
Other Non-Current Assets | -100 |
Free Cash Flow Analysis
Imagion Biosystems Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Imagion Biosystems Ltd
Revenue
|
1.2m
AUD
|
Operating Expenses
|
-3.4m
AUD
|
Operating Income
|
-2.2m
AUD
|
Other Expenses
|
127.1k
AUD
|
Net Income
|
-2.1m
AUD
|
IBX Profitability Score
Profitability Due Diligence
Imagion Biosystems Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Score
Imagion Biosystems Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
IBX Solvency Score
Solvency Due Diligence
Imagion Biosystems Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Score
Imagion Biosystems Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IBX Price Targets Summary
Imagion Biosystems Ltd
Dividends
Current shareholder yield for IBX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IBX
stock under the Base Case scenario is
0.02
AUD.
Compared to the current market price of 0.012 AUD,
Imagion Biosystems Ltd
is
Undervalued by 41%.